
Cardiac amyloidosis is increasingly recognized, yet remains highly lethal. Join experts and editors from @CircHF and @CircImaging to explore advances in diagnosis, imaging, and treatment. #ScientificSessions26 📅 Nov. 8 | 🕜 3:30-4:45 PM CT | 📍 N138

RT/follows do not imply endorsement.

Cardiac amyloidosis is increasingly recognized, yet remains highly lethal. Join experts and editors from @CircHF and @CircImaging to explore advances in diagnosis, imaging, and treatment. #ScientificSessions26 📅 Nov. 8 | 🕜 3:30-4:45 PM CT | 📍 N138

Cardiac amyloidosis is increasingly recognized, yet remains highly lethal. Join experts and editors from @CircHF and @CircImaging to explore advances in diagnosis, imaging, and treatment. #ScientificSessions26 📅 Nov. 8 | 🕜 3:30-4:45 PM CT | 📍 N138

Cardiac amyloidosis is increasingly recognized, yet remains highly lethal. Join experts and editors from @CircHF and @CircImaging to explore advances in diagnosis, imaging, and treatment. #ScientificSessions26 📅 Nov. 8 | 🕜 3:30-4:45 PM CT | 📍 N138

CT-derived fatty muscle fraction independently predicts 1-year mortality after MTEER, highlighting a new imaging biomarker of frailty. #MTEER #Frailty @UniklinikBonn @Vogelhuber_J ahajrnls.org/4A7FpOU

In 34,976 patients from the multicenter REFINE PET registry, impaired LVEF reserve independently predicted mortality, while negative reserve identified patients more likely to have high-risk multivessel or left-main CAD #CircImaging @Piotr_JSlomka ahajrnls.org/4imySbx

2/ @cjungMD A promising step toward safer, smarter interventions #CardioTwitter #MedTech doi.org/10.1161/CIRCIMAGING.…

1/ Immersive tech meets structural heart care: In a randomized trial (n=140), adding #VirtualReality to TAVI planning improved 3D anatomical understanding and reduced access-site bleeding — without increasing procedure time or contrast use ...

What can TAVR planning CT tell us beyond anatomy? 🔍 AI-derived 3D body composition improved mortality risk stratification. Lower subcutaneous fat volume and poorer muscle measures identified patients at higher risk after TAVR. @JanMBrendel @CIRC_MGH ahajrnls.org/4yVLQ7f


1/ Does age change how ischemia should guide revascularization? In >73,000 patients undergoing SPECT/PET MPI, ischemia remained prognostic across ages and identified patients with better outcomes after early revascularization across most age groups ...

18FDG-avidity is associated with adverse HF and arrhythmia outcomes only in genotype-negative patients without clear cardiac sarcoid. In absence of biopsy-proven sarcoid, immunosuppression doesn't modify disease courses @B_Naz_MD ahajrnls.org/4jlsP9C

Can we improve on the Agatston score? 🫀 The new CAC Volume & Density (CAC-VD) score is simple to calculate, accounts for the inverse association of calcium density with CHD risk, & improves risk prediction vs the Agatston score @hsbhatia @UCSDCards ahajrnls.org/3W1sT4v

📣Calling all #AHFTC Fellows!📣 @CircHF is proud to launch the 2nd year of the journal's free educational webinar series for current & past AHFTC fellows 📌9 live virtual sessions 📌New topic each session 📅Start Date: November 18, 2026 🔗Learn More: ahajournals.org/circheartfai…

Women with quantified DMR have lower ERO but more symptoms, less surgery if asymptomatic, and the same severe-ERO mortality threshold as men #EchoFirst @EssayaghBen @saranomaurice ahajrnls.org/3Vb1ZqJ

📣 #Stroke Bridge Seminar: Advancing Stroke Intervention: From Device Innovation to Clinical Practice 🗓️ Tuesday, October 6, 2026, 12:00-1:00 PM PDT | 19:00-20:00 UTC 🌟 Speakers: @JeremyHeitMDPHD & Matthew J. Gounis 🌟 Hosted by @Chenhsbbb 📎Register: ahajrnls.org/47p4Izo

New transvalvular flow criteria transform DSE in low-gradient AS, reducing indeterminate studies and improving patient selection for aortic valve intervention @AVamvakidou @PPibarot @JoaoLCavalcante @pe_bartko @imperialcollege ahajrnls.org/4yXwDCs